Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 286–300 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1567 Fragile X Syndrome (FMR1) Detection by PCR Test This test detects CGG repeat expansions in the FMR1 gene, which are associated with Fragile X syndrome.	Peripheral Whole Blood (EDTA)	3–4 Business Days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CGG repeat expansions in the FMR1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of Fragile X syndrome", "Carrier screening", "Evaluation of intellectual disability", "Evaluation of autism spectrum disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21660-5 ICD-10: Q99.2, Z14.8 Clinical summary This test detects CGG repeat expansions in the FMR1 gene, which are associated with Fragile X syndrome.
TEST-1273 Fragile X Tremor/Ataxia Syndrome (FXTAS) Genetic Test This diagnostic test evaluates the number of CGG repeats in the FMR1 gene to identify premutation or full mutation status associated with FXTAS.	Whole blood (EDTA, Lavender Top)	4 working days	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CGG trinucleotide repeat expansions in the FMR1 gene", "Premutation carrier status (55–200 repeats)", "Full mutation status (>200 repeats)"] Parameters [{"name": "FMR1 CGG Repeat Count", "reference_range": "< 55 repeats (Normal)"}] Preparation ["No specific fasting required", "Provide a full current medication list"] Indications ["Adults over 50 with progressive cerebellar ataxia and intention tremor", "Individuals with a family history suggestive of Fragile X-associated disorders", "Differential diagnosis of late-onset neurological symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 49255-1 ICD-10: G11.1, G11.8 Clinical summary This diagnostic test evaluates the number of CGG repeats in the FMR1 gene to identify premutation or full mutation status associated with FXTAS.
TEST-3038 FREM1 Gene (Bifid Nose) Genetic Test This test identifies mutations in the FREM1 gene associated with bifid nose, a congenital craniofacial anomaly.	Peripheral whole blood (3–5 mL EDTA) or FTA card blood spot or extracted DNA	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FREM1 gene sequence variants", "Pathogenic mutations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Pedigree chart (family history) required"] Indications ["Diagnosis confirmation of bifid nose", "Familial risk assessment", "Surgical planning guidance"] Measurement technique Confirm with laboratory Codes LOINC: 82321-5 ICD-10: Q30.2, Q18.8 Clinical summary This test identifies mutations in the FREM1 gene associated with bifid nose, a congenital craniofacial anomaly.
TEST-3420 FSHB Gene (Follicle-Stimulating Hormone Beta Subunit) Deficiency Test This test evaluates the FSHB gene for pathogenic variants associated with isolated FSH deficiency and hypogonadotropic hypogonadism.	Whole Blood (EDTA) or Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the FSHB gene", "Copy number analysis of the FSHB gene"] Parameters [{"name": "FSHB Gene Sequencing", "reference_range": null}, {"name": "Copy Number Analysis", "reference_range": null}] Preparation ["No fasting required", "Mandatory genetic counselling session before sample collection", "Provide detailed medical history and family pedigree chart"] Indications ["Diagnosis of isolated FSH deficiency", "Evaluation of hypogonadotropic hypogonadism", "Family planning for individuals with FSHB-related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 21658-6 ICD-10: E23.0 Clinical summary This test evaluates the FSHB gene for pathogenic variants associated with isolated FSH deficiency and hypogonadotropic hypogonadism.
TEST-3429 FSHR Gene Ovarian Dysgenesis Type 1 Genetic Test This genetic test evaluates the FSHR gene for pathogenic variants associated with ovarian dysgenesis type 1.	Peripheral Blood (Whole Blood) or Buccal Swab (DNA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["FSHR gene mutations", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Clinical signs suggesting ovarian dysgenesis", "Strong family history of ovarian dysgenesis", "Primary amenorrhea", "Infertility"] Measurement technique Confirm with laboratory Codes LOINC: 21634-7 ICD-10: Q50.3 Clinical summary This genetic test evaluates the FSHR gene for pathogenic variants associated with ovarian dysgenesis type 1.
TEST-6185 G6PC2 Gene Hyperinsulinaemia Genetic Test This genetic test identifies pathogenic variants in the G6PC2 gene associated with congenital hyperinsulinism.	Whole Blood (3 mL), FTA Card Blood Spot, or Extracted DNA	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the G6PC2 gene"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "No specific fasting required for sample collection"] Indications ["Documented non-ketotic hypoglycaemia", "Family history of congenital hyperinsulinism (CHI)", "Unclear response to diazoxide therapy"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E16.1 Clinical summary This genetic test identifies pathogenic variants in the G6PC2 gene associated with congenital hyperinsulinism.
TEST-6379 G6PD Deficiency (Favism) Susceptibility Genetic Test This genetic test identifies variants in the G6PD gene associated with favism, a condition causing hemolytic anemia upon exposure to specific triggers.	Whole Blood (peripheral), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["G6PD gene variants", "Susceptibility to favism"] Parameters [] Preparation ["No fasting or special preparation required", "Mandatory pre-test genetic counselling session"] Indications ["Family history of G6PD deficiency", "Suspicion of favism", "Screening individuals at risk"] Measurement technique Confirm with laboratory Codes LOINC: 82794-6 ICD-10: D55.0 Clinical summary This genetic test identifies variants in the G6PD gene associated with favism, a condition causing hemolytic anemia upon exposure to specific triggers.
TEST-3283 G6PD Gene (Favism) Susceptibility Genetic Test This test evaluates the G6PD gene for pathogenic variants associated with G6PD deficiency, a condition causing red blood cell breakdown.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["G6PD gene sequence", "Pathogenic variants in G6PD gene"] Parameters [] Preparation ["No fasting required", "Brief genetic counseling session recommended prior to sample collection"] Indications ["Family history of G6PD deficiency", "Unexplained hemolytic anemia", "Pre-exposure screening for triggering drugs/foods", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 96512-1 ICD-10: D55.0, Z13.89 Clinical summary This test evaluates the G6PD gene for pathogenic variants associated with G6PD deficiency, a condition causing red blood cell breakdown.
TEST-5937 GAA Gene Pompe Disease Genetic Test This genetic test identifies pathogenic variants in the GAA gene, confirming a diagnosis of Pompe disease (glycogen storage disease type II). It provides crucial information for gu...	Peripheral whole blood, FTA card, or extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GAA gene pathogenic variants", "Cryptic splice-site variants", "Large deletions"] Parameters [] Preparation [] Indications ["Suspected Pompe disease", "Family history of Pompe disease", "Eligibility assessment for ERT", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 78416-5 ICD-10: E74.02 Clinical summary This genetic test identifies pathogenic variants in the GAA gene, confirming a diagnosis of Pompe disease (glycogen storage disease type II). It provides crucial information for guiding treatment and family screening.
TEST-4277 GABRB1 Gene Early Infantile Epileptic Encephalopathy Type 45 Genetic Test This test evaluates the GABRB1 gene for pathogenic variants associated with early infantile epileptic encephalopathy type 45 (EIEE45).	Peripheral whole blood or FTA blood spot	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GABRB1 gene", "Genetic mutations associated with EIEE45"] Parameters [] Preparation ["Mandatory genetic counselling session required prior to testing", "Informed consent documentation required"] Indications ["Infants presenting with drug-resistant seizures", "Suspected early infantile epileptic encephalopathy type 45 (EIEE45)", "Family history of GABRB1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G40.4 Clinical summary This test evaluates the GABRB1 gene for pathogenic variants associated with early infantile epileptic encephalopathy type 45 (EIEE45).
TEST-4339 GABRB3 Gene Epilepsy (Childhood Absence Type 5) Genetic Test This test identifies mutations in the GABRB3 gene associated with childhood absence epilepsy type 5.	Whole Blood (EDTA) – Peripheral	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GABRB3 gene mutations"] Parameters [] Preparation [] Indications ["Suspected childhood absence epilepsy type 5", "Family history of childhood absence epilepsy type 5"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G40.309 Clinical summary This test identifies mutations in the GABRB3 gene associated with childhood absence epilepsy type 5.
TEST-3982 GAD1 Gene Cerebral Palsy Type 1, Spastic Quadriplegic Genetic Test This genetic test evaluates for pathogenic variants in the GAD1 gene associated with autosomal recessive spastic quadriplegic cerebral palsy type 1.	Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GAD1 gene"] Parameters [] Preparation [] Indications ["Suspected GAD1-related cerebral palsy", "Family history of GAD1-related cerebral palsy", "Genetic counseling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G82.4 Clinical summary This genetic test evaluates for pathogenic variants in the GAD1 gene associated with autosomal recessive spastic quadriplegic cerebral palsy type 1.
TEST-1280 Galactosemia (GALT) Gene Mutation Detection Test This test identifies pathogenic variants in the GALT gene, confirming a diagnosis of classic galactosemia.	Whole Blood (EDTA Lavender Top Tube)	15 Business Days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GALT gene"] Parameters [] Preparation ["No fasting or special preparation is needed."] Indications ["Neonates with symptoms suggestive of galactosemia", "Newborns with positive newborn screening results", "Families with a known history of galactosemia", "Carrier screening for individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 32196-4 ICD-10: E74.21 Clinical summary This test identifies pathogenic variants in the GALT gene, confirming a diagnosis of classic galactosemia.
TEST-4619 GALC Gene Krabbe Disease Genetic Test This test evaluates the GALC gene for mutations associated with Krabbe disease.	Whole Blood, Extracted DNA, Dried Blood Spot (FTA Card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GALC gene", "Copy Number Variations (CNV) in the GALC gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnostic confirmation of suspected Krabbe disease", "Carrier screening for individuals with family history", "Presymptomatic testing in at-risk individuals"] Measurement technique Confirm with laboratory Codes LOINC: 94056-2 ICD-10: E75.23 Clinical summary This test evaluates the GALC gene for mutations associated with Krabbe disease.
TEST-5988 GALNS Gene Mucopolysaccharidosis Type IVA Genetic Test This genetic test sequences the GALNS gene to identify pathogenic variants associated with Mucopolysaccharidosis Type IVA (Morquio A Syndrome). It provides a definitive molecular d...	Peripheral Whole Blood (EDTA), FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GALNS gene", "Copy Number Variations (CNV) in the GALNS gene"] Parameters [] Preparation ["A detailed clinical history of the patient is mandatory.", "A genetic counselling session must be undertaken to draw a pedigree chart."] Indications ["Clinical suspicion of Mucopolysaccharidosis Type IVA (Morquio A Syndrome)", "Carrier screening for family planning", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 83365-7 ICD-10: E76.2 Clinical summary This genetic test sequences the GALNS gene to identify pathogenic variants associated with Mucopolysaccharidosis Type IVA (Morquio A Syndrome). It provides a definitive molecular diagnosis for affected individuals.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.